Kolmar BioTech, Inc. (KOSDAQ:215380)
South Korea · Delayed Price · Currency is KRW 2,100.00
-40.00 (-1.87%)
At close: Sep 3, 2026
Kolmar BioTech Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,757 | 3,834 | 4,019 | 5,416 | 3,577 | 455.29 |
Short-Term Investments | 35,330 | 285 | 428.3 | 330 | 1,423 | 6,470 |
Cash & Short-Term Investments | 37,087 | 4,119 | 4,448 | 5,746 | 5,000 | 6,926 |
Cash Growth | 531.55% | -7.40% | -22.60% | 14.93% | -27.80% | -56.64% |
Accounts Receivable | 3,426 | 3,735 | 5,797 | 6,933 | 2,448 | 5,768 |
Other Receivables | 1,800 | 10.83 | 46.77 | 35.05 | 20.73 | 243.64 |
Receivables | 5,225 | 3,746 | 5,846 | 6,968 | 2,469 | 6,012 |
Inventory | 8,801 | 7,971 | 4,969 | 4,338 | 3,586 | 4,390 |
Prepaid Expenses | 204.07 | 229.05 | 1,472 | 111.89 | 98.45 | 137.43 |
Other Current Assets | 1,220 | 1,071 | 3,194 | 2,526 | 2,734 | 7,704 |
Total Current Assets | 52,537 | 17,135 | 19,928 | 19,690 | 13,887 | 25,169 |
Property, Plant & Equipment | 46,998 | 47,463 | 51,581 | 56,130 | 63,715 | 57,281 |
Long-Term Investments | 1,914 | 1,929 | 2,597 | 1,866 | 2,676 | 2,635 |
Other Intangible Assets | 875.87 | 885.43 | 918.11 | 966.72 | 1,016 | 995.56 |
Long-Term Accounts Receivable | 0 | -0 | -0 | -0 | 0 | 0 |
Other Long-Term Assets | 19,298 | 19,383 | 19,675 | 19,680 | 13,700 | 14,056 |
Total Assets | 121,622 | 86,795 | 94,699 | 98,333 | 94,994 | 100,136 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5,588 | 3,610 | 3,138 | 1,134 | 1,406 | 1,578 |
Accrued Expenses | 487.13 | 420.16 | 482.88 | 495.56 | 691.9 | 475.11 |
Short-Term Debt | 21,527 | 19,687 | 20,227 | 25,647 | 22,618 | 10,575 |
Current Portion of Long-Term Debt | 555.4 | - | - | - | - | - |
Current Portion of Leases | 129.05 | 137.33 | 210.55 | 468.54 | 207.33 | 407.47 |
Other Current Liabilities | 36,982 | 6,214 | 7,290 | 17,953 | 20,320 | 24,506 |
Total Current Liabilities | 65,268 | 30,068 | 31,348 | 45,699 | 45,244 | 37,542 |
Long-Term Debt | 30,417 | 30,500 | 30,305 | 25,004 | 17,674 | 27,739 |
Long-Term Leases | 169.25 | 197.55 | 241.86 | 1,197 | 186.52 | 356.22 |
Pension & Post-Retirement Benefits | 2,147 | 2,163 | 2,983 | 3,960 | 1,878 | 1,983 |
Other Long-Term Liabilities | 454.17 | 488.64 | 447.41 | 501.47 | 293.63 | 587.67 |
Total Liabilities | 98,455 | 63,417 | 65,326 | 76,361 | 65,275 | 68,208 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 8,415 | 8,415 | 8,415 | 6,479 | 6,479 | 6,436 |
Additional Paid-In Capital | 48,612 | 48,612 | 48,612 | 43,201 | 43,201 | 42,741 |
Retained Earnings | -31,266 | -31,055 | -25,060 | -25,114 | -18,397 | -16,300 |
Treasury Stock | -2,006 | -2,006 | -2,006 | -2,006 | -2,006 | -2,006 |
Comprehensive Income & Other | -587.01 | -587.01 | -587.01 | -587.01 | 441.61 | 588.99 |
Total Common Equity | 23,167 | 23,378 | 29,373 | 21,972 | 29,718 | 31,460 |
Shareholders' Equity | 23,167 | 23,378 | 29,373 | 21,972 | 29,718 | 31,928 |
Total Liabilities & Equity | 121,622 | 86,795 | 94,699 | 98,333 | 94,994 | 100,136 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 52,797 | 50,522 | 50,985 | 52,316 | 40,685 | 39,078 |
Net Cash (Debt) | -15,710 | -46,403 | -46,537 | -46,570 | -35,685 | -32,152 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -942.00 | -2500.55 | -3098.34 | -3639.87 | -2771.02 | -2688.00 |
Filing Date Shares Outstanding | 16.67 | 16.67 | 16.67 | 12.8 | 12.8 | 12.71 |
Total Common Shares Outstanding | 16.67 | 16.67 | 16.67 | 12.8 | 12.8 | 12.71 |
Working Capital | -12,731 | -12,933 | -11,420 | -26,008 | -31,357 | -12,373 |
Book Value Per Share | 1389.72 | 1402.35 | 1761.97 | 1716.77 | 2322.02 | 2474.52 |
Tangible Book Value | 22,291 | 22,493 | 28,455 | 21,005 | 28,702 | 30,465 |
Tangible Book Value Per Share | 1337.18 | 1349.24 | 1706.89 | 1641.24 | 2242.63 | 2396.21 |
Land | 2,858 | 2,858 | 2,858 | 2,858 | 8,986 | 2,837 |
Buildings | 41,941 | 41,941 | 41,941 | 41,941 | 41,941 | 39,502 |
Machinery | 14,661 | 14,683 | 15,391 | 15,437 | 15,152 | 13,898 |
Construction In Progress | - | - | 81 | 70.84 | 4,279 | 4,260 |